Table 3.
Outcomes at the end of the intervention by sex and access route.
| Quantitative outcomes | All participants | Occupational health access | Community access | ||||
|---|---|---|---|---|---|---|---|
| N* | Change† Mean (95% CI) |
N* | Change† Mean (95% CI) |
N* | Change† Mean (CI95%) |
||
| Weight | All | 1020 | 4.3 (4.1–4.6) | 450 | 5.5 (5.0–6.0) | 570 | 3.4 (3.1–3.7) |
| Males | 275 | 6.1 (5.4–6.8) | 176 | 7.0 (6.1–8.0) | 99 | 4.5 (3.5–5.5) | |
| Females | 741 | 3.7 (3.4–3.9) | 273 | 4.5 (4.0–5.1) | 468 | 3.2 (2.9–3.4) | |
| Waist circumference | All | 610 | 4.2 (3.8–4.6) | 205 | 6.0 (5.3–6.8) | 405 | 3.3 (2.8–3.7) |
| Males | 155 | 6.0 (5.1–6.9) | 84 | 7.3 (6.0–8.6) | 71 | 4.5 (3.4–5.6) | |
| Females | 453 | 3.6 (3.1–4.0) | 120 | 5.2 (4.2–6.1) | 333 | 3.0 (2.5–3.5) | |
| Body mass index | All | 1010 | 1.6 (1.5–1.7) | 440 | 2.0 (1.8–2.2) | 570 | 1.3 (1.2–1.4) |
| Males | 279 | 2.0 (1.8–2.2) | 174 | 2.4 (2.1–2.7) | 105 | 1.4 (1.1–1.7) | |
| Females | 727 | 1.5 (1.4–1.6) | 265 | 1.8 (1.6–2.0) | 462 | 1.3 (1.2–1.4) | |
| Qualitative outcomes | N* | Success % (95% CI) | N* | Success % (95% CI) | N * | Success % (CI 95%) | |
|---|---|---|---|---|---|---|---|
| 5% reduction in baseline weight | All | 1020 | 43.0 (40.0–46.1) | 450 | 51.1 (46.5–55.7) | 570 | 36.7 (32.7–40.6) |
| Males | 275 | 53.1 (47.2–59.0) | 176 | 57.9 (50.6–65.3) | 99 | 44.4 (34.5–54.4) | |
| Females | 741 | 39.4 (35.9–42.3) | 273 | 46.9 (40.9–52.8) | 468 | 35.0 (30.7–39.4) | |
| Smaller waist circumference | All | 610 | 79.2 (75.9–82.4) | 205 | 87.3 (82.7–91.9) | 405 | 75.1 (70.8–79.3) |
| Males | 155 | 88.4 (83.3–93.5) | 84 | 92.8 (87.2–98.5) | 71 | 83.1 (74.2–92.0) | |
| Females | 453 | 75.9 (72.0–79.9) | 120 | 83.3 (76.6–90.1) | 333 | 73.3 (68.5–78.0) | |
| Lower BMI classification | All | 1010 | 19.3 (16.9–21.7) | 440 | 22.5 (18.6–26.4) | 570 | 16.8 (13.8–19.9) |
| Males | 279 | 26.5 (21.3–31.7) | 174 | 27.6 (20.9–34.3) | 105 | 24.8 (16.4–33.2) | |
| Females | 727 | 16.6 (13.9–19.4) | 265 | 19.2 (14.5–24.0) | 462 | 15.1 (11.9–18.4) | |
| Initially obese participants who are no longer obese | All | 660 | 22.3 (19.1–25.5) | 295 | 26.1 (21.1–31.1) | 365 | 19.2 (15.1–23.2) |
| Males | 207 | 30.4 (24.1–36.8) | 124 | 34.7 (26.2–43.2) | 83 | 24.1 (14.7–33.5) | |
| Females | 450 | 18.7 (15.0–22.3) | 170 | 20.0 (13.9–26.1) | 280 | 17.9 (13.3–22.4) | |
| Initially overweight participants who revert to normal weight | All | 315 | 15.2 (11.2–19.2) | 135 | 16.3 (10.0–22.6)) | 180 | 14.4 (9.3–19.6) |
| Males | 69 | 15.9 (7.1–24.8) | 48 | 10.4 (1.4–19.4) | 21 | 28.6 (7.5–48.6) | |
| Females | 246 | 15.4 (10.5–19.5) | 87 | 14.4 (9.3–19.6) | 159 | 12.6 (7.4–17.8) | |
| High risk participants who revert to normoglycemia | All | 188 | 35.1 (28.2–42.0) | 125 | 44.0 (35.2–52.8) | 63 | 17.5 (7.8–27.1) |
| Males | 69 | 47.8 (35.7–59.9) | 56 | 51.8 (38.3–65.3) | 13 | 30.8 (1.7–59.8) | |
| Females | 119 | 27.7 (19.6–35.9) | 69 | 37.7 (25.9–49.4) | 50 | 14.0 (4.0–24.0) | |
*Sample size with complete data for the calculation of the parameter.
†All the changes are negative, and all Student’s t tests for the pre-postintervention difference of means had a p-value < 0.01.